Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study On the Expression Level and Clinical Significance of VISTA in Patients With Vascular Cognitive Impairment

NCT06342661 is registered in ClinicalTrials.gov with First Affiliated Hospital of Harbin Medical University as lead sponsor.

NCT NCT06342661
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06342661 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study On the Expression Level and Clinical Significance of VISTA in Patients With Vascular Cognitive Impairment
Lead sponsor
First Affiliated Hospital of Harbin Medical University
Phase
Observational
Overall status
Recruiting
Start date
March 1, 2023
Completion date
November 30, 2028
Enrollment
400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cerebrovascular disease small vessel